LRRK2 and Parkinson disease: Mutations in leucine-rich repeat kinase 2 (LRRK2) are one of the most common drivers of the familial form of Parkinson’s disease (PD) (1–3) and are also associated with increased risk for the sporadic form of PD (1, 4).